RESIDUAL DISEASE
Clinical trials for RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to stop breast Cancer's return in High-Risk patients
Disease control Recruiting nowThis study tests whether adding tetrathiomolybdate (TM) to standard capecitabine can lower the chance of breast cancer returning in patients with high-risk triple-negative breast cancer. About 204 participants who have completed initial treatment and surgery will receive either T…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
Blood test catches hidden breast cancer before scans can see it
Disease control Recruiting nowThis study is for people with a high-risk type of breast cancer (triple negative) who still have cancer after standard treatment and surgery. Researchers will use a simple blood test to look for tiny bits of cancer DNA that might be left in the body. If the blood test finds cance…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC